Topline results expected in fourth quarter of 2024GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:…
Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and regulatory…
Company actively advancing lead ophthalmology drug candidate to first Investigational New Drug (IND) filingREDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE…
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a…
The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded…
ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured by…
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform…
ZORYVE® (roflumilast) cream 0.15% improved atopic dermatitis (AD) across multiple efficacy endpoints while demonstrating favorable safety and tolerabilityAcross both studies,…
BERKELEY HEIGHTS, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic…
PsyLabs develops and produces certified pharmaceutical-grade natural psychedelics for applications in mental health and well-beingNEW YORK, Sept. 19, 2024 (GLOBE…